NALTREXONE HYDROCHLORIDE (DEPADE, REVIA)

Course overview

Naltrexone is U.S. FDA-approved for prevention of opiate dependence relapse and maintenance of alcohol abstinence, as an adjunct to medically-supervised behavior modification therapy. It must be used cautiously in alcohol-dependent patients, and in patients with active liver disease; moderate/severe renal impairment; thrombocytopenia or coagulation disorders; or history of attempted suicide with or without depression. This continuing education module is designed to give the reader/learner an increased understanding of naltrexone. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.